Global Pulmonary Arterial Hypertension Market Size & Outlook
The pulmonary arterial hypertension industry worldwide is expected to reach a projected revenue of US$ 10,609.4 million by 2030. A compound annual growth rate of 5.3% is expected of the worldwide pulmonary arterial hypertension industry from 2024 to 2030.
Revenue, 2023 (US$M)
$7,377.6
Forecast, 2030 (US$M)
$10,609.4
CAGR, 2024 - 2030
5.3%
Report Coverage
Worldwide
Global pulmonary arterial hypertension market, 2018-2030 (US$M)
Related Markets
Global pulmonary arterial hypertension market highlights
- The global pulmonary arterial hypertension market generated a revenue of USD 7,377.6 million in 2023 and is expected to reach USD 10,609.4 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 5.3% by 2030.
- In terms of segment, prostacyclin and prostacyclin analogs accounted for a revenue of USD 3,487.0 million in 2023.
- SGC Stimulators is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Denmark is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 7,377.6 million |
| Market revenue in 2030 | USD 10,609.4 million |
| Growth rate | 5.3% (CAGR from 2023 to 2030) |
| Largest segment | Prostacyclin and prostacyclin analogs |
| Fastest growing segment | SGC Stimulators |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators |
Other key industry trends
- In terms of revenue, the North America accounted for 43.7% of the global pulmonary arterial hypertension market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Denmark is the fastest growing regional market and is projected to reach USD 78.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pulmonary Arterial Hypertension Market Scope
Pulmonary arterial hypertension market segmentation & scope
Pulmonary Arterial Hypertension Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global pulmonary arterial hypertension market size, by region, 2018-2030 (US$M)
Top 10 countries: Pulmonary arterial hypertension market size, 2023 (US$M)
Global pulmonary arterial hypertension market share, by drug class, 2023 & 2030 (%, US$M)
Pulmonary arterial hypertension market: Opportunity assessment by country
Global pulmonary arterial hypertension market, by region, 2023 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
